Profiel
Bo Ren Xue is the founder of ACT Genomics Co. Ltd. Mr. Xue is currently President, Chief Operating Officer & Director at AnBogen Therapeutics, Inc. since 2022.
Mr. Xue is also Vice President-Corporate Operations at TaiGen Biotechnology Co., Ltd. since 2001.
Formerly, Mr. Xue was President at AnBogen Therapeutics, Inc. Mr. Xue earned an MBA from Fairleigh Dickinson University in 1997 and completed undergraduate studies at Soochow University.
Actieve functies van Bo Ren Xue
| Bedrijven | Functie | Begin |
|---|---|---|
| ANBOGEN THERAPEUTICS, INC. | President | 01-05-2022 |
TaiGen Biotechnology Co., Ltd.
TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of drugs | Operationeel Directeur | 02-10-2012 |
ACT Genomics Co. Ltd.
ACT Genomics Co. Ltd. Hospital/Nursing ManagementHealth Services Provides cancer solutions | Oprichter | - |
Eerdere bekende functies van Bo Ren Xue
| Bedrijven | Functie | Einde |
|---|---|---|
| ANBOGEN THERAPEUTICS, INC. | President | - |
Opleiding van Bo Ren Xue
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Fairleigh Dickinson University
Fairleigh Dickinson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TaiGen Biotechnology Co., Ltd.
TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of drugs | Health Technology |
Soochow University
Soochow University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ACT Genomics Co. Ltd.
ACT Genomics Co. Ltd. Hospital/Nursing ManagementHealth Services Provides cancer solutions | Health Services |
AnBogen Therapeutics, Inc.
AnBogen Therapeutics, Inc. BiotechnologyHealth Technology Engages in development and sale of cancer precise medical drugs | Health Technology |
















